Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 6.99
(-1.55%)
CNY 6.99
(-1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 890.71 Million | 765.88 Million | 843.9 Million | 827.33 Million | 819.11 Million | 608.05 Million |
| Cost of Revenue | 517.18 Million | 341.65 Million | 309.82 Million | 276.48 Million | 254.76 Million | 200.42 Million |
| Gross Profit | 373.52 Million | 424.22 Million | 534.08 Million | 550.85 Million | 564.35 Million | 407.62 Million |
| Operating Expenses | 519.14 Million | 393.12 Million | 405.82 Million | 394.11 Million | 365.84 Million | 253.28 Million |
| Selling, General and Administrative Expenses | 236.84 Million | 229.51 Million | 304.49 Million | 312.81 Million | 290.38 Million | 208.07 Million |
| Research and Development Expenses | 122.32 Million | 99 Million | 47.22 Million | 51.71 Million | 50.68 Million | 28.07 Million |
| Other Expenses | 49.21 Million | 24.75 Million | 9.07 Million | 10.11 Million | -1.53 Million | -1.88 Million |
| Cost and Expenses | 991.15 Million | 734.77 Million | 715.64 Million | 670.6 Million | 620.6 Million | 453.7 Million |
| Operating Income | -100.43 Million | -13.28 Million | 125.79 Million | 183.12 Million | 400.47 Million | 166.75 Million |
| Interest Expense | 53.13 Million | 47.64 Million | 44.18 Million | 4.84 Million | 131.35 Thousand | 2.35 Million |
| Income Tax Expense | -17.95 Million | -10.14 Million | 12.06 Million | 19.84 Million | 54.33 Million | 17.1 Million |
| Earnings before Tax | -101.15 Million | -14.76 Million | 120.97 Million | 173.83 Million | 396.77 Million | 164.86 Million |
| Net Income | -71.75 Million | 11.28 Million | 125.51 Million | 174.7 Million | 342.43 Million | 147.76 Million |
| Earnings Per Share Basic | -0.15 | 0.02 | 0.26 | 0.36 | 0.70 | 0.30 |
| Earnings Per Share Diluted | -0.15 | 0.02 | 0.26 | 0.36 | 0.70 | 0.30 |
| Weighted Average Shares Outstanding | 478.38 Million | 491.95 Million | 482.74 Million | 485.28 Million | 489.19 Million | 492.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 478.38 Million | 491.95 Million | 482.74 Million | 485.28 Million | 489.19 Million | 492.53 Million |
| Gross Margin | 0.42 | 0.55 | 0.63 | 0.67 | 0.69 | 0.67 |
| EBIT Margin | 0.04 | 0.17 | 0.27 | 0.27 | 0.06 | 0.29 |
| Profit Margin | -0.08 | 0.01 | 0.15 | 0.21 | 0.42 | 0.24 |
| EBITDA | 36.44 Million | 110.53 Million | 229.82 Million | 222.64 Million | 219.13 Million | 171.9 Million |
| Earnings Before Tax Margin | -0.11 | -0.02 | 0.15 | 0.22 | 0.49 | 0.27 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 255.78 Million | 262.94 Million | 207.5 Million | 890.71 Million | 240.89 Million | 211.78 Million |
| Cost of Revenue | 131.01 Million | 149.86 Million | 92.1 Million | 472 Million | 140.13 Million | 110.82 Million |
| Gross Profit | 124.77 Million | 113.08 Million | 115.4 Million | 418.7 Million | 100.76 Million | 100.95 Million |
| Operating Expenses | 105.61 Million | 97.86 Million | 84.03 Million | 418.8 Million | 120.44 Million | 102.59 Million |
| Selling, General and Administrative Expenses | 149.36 Million | 76.26 Million | 70.09 Million | - | 26.9 Million | 100.43 Million |
| Research and Development Expenses | 17.72 Million | 19.21 Million | 13.88 Million | - | 35.98 Million | 32.64 Million |
| Other Expenses | -61.47 Million | -2.38 Million | 45.6 Thousand | -11.88 Million | -12.58 Million | -6.79 Million |
| Cost and Expenses | 236.62 Million | 247.72 Million | 176.13 Million | 890.81 Million | 260.57 Million | 213.42 Million |
| Operating Income | 2.3 Million | 15.21 Million | 15.86 Million | -100.43 Million | -90.7 Million | -11.84 Million |
| Interest Expense | 15.86 Million | 14.39 Million | 13.76 Million | 53.13 Million | 13.47 Million | 14.28 Million |
| Income Tax Expense | -2.16 Million | 948.72 Thousand | 4.28 Million | -17.95 Million | -13.13 Million | -2.93 Million |
| Earnings before Tax | 1.63 Million | 3.82 Million | 15.9 Million | -101.15 Million | -92.12 Million | -12.1 Million |
| Net Income | 4.85 Million | 8.01 Million | 11.52 Million | -71.75 Million | -73.69 Million | -7.65 Million |
| Earnings Per Share Basic | 0.01 | 0.02 | 0.02 | - | -0.16 | -0.02 |
| Earnings Per Share Diluted | 0.01 | 0.02 | 0.02 | - | -0.16 | -0.02 |
| Weighted Average Shares Outstanding | 491.93 Million | 491.93 Million | 490.47 Million | 478.38 Million | 457.25 Million | 491.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 491.93 Million | 491.93 Million | 277.73 Million | 1.02 Billion | 457.25 Million | 491.93 Million |
| Gross Margin | 0.49 | 0.43 | 0.56 | 0.47 | 0.42 | 0.48 |
| EBIT Margin | 0.07 | 0.15 | 0.16 | - | -0.10 | -0.03 |
| Profit Margin | 0.02 | 0.03 | 0.06 | -0.08 | -0.31 | -0.04 |
| EBITDA | 17.5 Million | 38.5 Million | 33.3 Million | - | -23.18 Million | -6.64 Million |
| Earnings Before Tax Margin | 0.01 | 0.06 | 0.08 | -0.11 | -0.38 | -0.06 |
COMFINCAP
009770
600839
RTC
TPTA
PAYT